Sources and updates, February 26
Sources and updates for the week of February 26 include deaths in U.S. prisons, the future of COVID-19 vaccines, airplane wastewater testing, and more.
Read MoreCategory: Vaccines
Sources and updates, February 12
Sources and updates for the week of February 12 include routine vaccinations for kids, variant analysis in China, ME/CFS research, and more.
Read MoreSources and updates, February 5
Sources and updates for the week of February 5 include modeling persistent COVID-19 risk, global vaccination coverage, COVID-related lawsuits, and more.
Read MoreThe future of COVID-19 vaccines needs more data
On Thursday, the FDA’s Vaccines and Related Biological Products Advisory Committee (or VRBPAC) met to discuss the future of COVID-19 vaccines. While the committee readily agreed that our current, Omicron-specific shots are working well and should be used more broadly, it had a hard time answering other questions about future vaccine regimens—largely due to a lack of good data.
Read MoreSources and updates, December 18
Sources and updates for the week of December 18 include at-home test orders, lives saved by vaccines, state-level wastewater surveillance, and more.
Read MoreSources and updates, December 11
Sources and updates for the week of December 11 include America’s Health Rankings, bivalent boosters for kids, and more.
Read MoreSources and updates, December 4
Sources and updates for the week of December 4 include new CDC grants to support public health infrastructure, breakthrough COVID-19 deaths, monoclonal antibodies, and more.
Read MoreSources and updates, November 20
Sources and updates for the week of November 20 include mortality trends, bivalent boosters, perceptions of COVID-19 trends, and more.
Read MoreSources and updates, November 13
Sources and updates for the week of November 13 include booster shot uptake by state, masks in schools, Paxlovid for Long COVID, and more.
Read MoreSources and updates, November 6
Sources and updates for the week of November 6 include Omicron bivalent boosters, a Long COVID clinical trial, an RSV vaccine, and more.
Read More